Information Journal Paper
APA:
Copy. (2019). The docetaxel debate: impact of chemotherapy in high-risk non-metastatic prostate cancer. Transl Androl Urol, 8(supplement 3), 303-306. SID. https://sid.ir/paper/775894/en
Vancouver:
Copy. The docetaxel debate: impact of chemotherapy in high-risk non-metastatic prostate cancer. Transl Androl Urol[Internet]. 2019;8(supplement 3):303-306. Available from: https://sid.ir/paper/775894/en
IEEE:
Copy, “The docetaxel debate: impact of chemotherapy in high-risk non-metastatic prostate cancer,” Transl Androl Urol, vol. 8, no. supplement 3, pp. 303–306, 2019, [Online]. Available: https://sid.ir/paper/775894/en